Evidence map›Paper›PMID 17335798›Full record

ArticleDevelopmental biology2007

Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish.

Jon M Davison, Courtney M Akitake, Mary G Goll, Jerry M Rhee, Nathan Gosse, Herwig Baier, Marnie E Halpern, Steven D Leach, Michael J Parsons

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 249 papers.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 454 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Enteroendocrine cells wire the gut-brain vagal axis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jon M DavisonDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Courtney M Akitake
Mary G Goll
Jerry M Rhee
Nathan Gosse
Herwig Baier
Marnie E Halpern
Steven D Leach
Michael J Parsons
Johns Hopkins University · USCarnegie Institution for Science · USUniversity of California, San Francisco · US

Funding

JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI AHIMA, REXFORD S. · 2013 to 2017
$9.7M
SURGICAL STUDIES OF PANCREATIC STEM CELLSR01DK056211 · NIDDK · VANDERBILT UNIVERSITY · PI LEACH, STEVEN D · 1999 to 2014
$4.9M
Regulation of Exocrine Pancreatic Progenitors by Ptf1a-p48R01DK061215 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEACH, STEVEN D · 2002 to 2012
$3.3M
Left-Right Asymmetry of the Developing DiencephalonR01HD042215 · NICHD · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI HALPERN, MARNIE E · 2003 to 2013
$3.3M
NICHD NIH HHS HD042215NICHD NIH HHS R01 HD042215NIDDK NIH HHS DK56211NIDDK NIH HHS DK61215NIDDK NIH HHS P30 DK079637NIDDK NIH HHS R01 DK056211NIDDK NIH HHS R01 DK061215NINDS NIH HHS 1F31NS05097
6 · The paper itself

Abstract

Prior studies with transgenic zebrafish confirmed the functionality of the transcription factor Gal4 to drive expression of other genes under the regulation of upstream activator sequences (UAS). However, widespread application of this powerful binary system has been limited, in part, by relatively inefficient techniques for establishing transgenic zebrafish and by the inadequacy of Gal4 to effect high levels of expression from UAS-regulated genes. We have used the Tol2 transposition system to distribute a self-reporting gene/enhancer trap vector efficiently throughout the zebrafish genome. The vector uses the potent, hybrid transcription factor Gal4-VP16 to activate expression from a UAS:eGFP reporter cassette. In a pilot screen, stable transgenic lines were established that express eGFP in reproducible patterns encompassing a wide variety of tissues, including the brain, spinal cord, retina, notochord, cranial skeleton and muscle, and can transactivate other UAS-regulated genes. We demonstrate the utility of this approach to track Gal4-VP16 expressing migratory cells in UAS:Kaede transgenic fish, and to induce tissue-specific cell death using a bacterial nitroreductase gene under UAS control. The Tol2-mediated gene/enhancer trapping system together with UAS transgenic lines provides valuable tools for regulated gene expression and for targeted labeling and ablation of specific cell types and tissues during early zebrafish development.

Indexed as

Enhancer Elements, GeneticAnimalsAnimals, Genetically ModifiedCell DeathDNA Transposable ElementsEscherichia coli ProteinsGene Expression Regulation, DevelopmentalGenes, ReporterGreen Fluorescent ProteinsNitroreductasesOrgan SpecificityTrans-ActivatorsTranscriptional ActivationZebrafishDNA Transposable Elementsenhanced green fluorescent proteinEscherichia coli ProteinsGal-VP16Green Fluorescent ProteinsNfsB protein, E coliNitroreductasesTrans-Activators

Identifiers

PMID17335798
PMCPMC3470427
OpenAlexW1992938999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.